Saman Ahsan is a Partner in the Dispute Resolution Practice Group in the New Delhi office. Prior to joining Khaitan & Co, Saman worked in the litigation and international commercial arbitration team of a reputed law firm, in London.
Saman has rich experience of over a decade in the field of dispute resolution and has advised clients on a wide variety of claims under Indian arbitration laws, SIAC, LCIA, ICC, and HKIAC. She regularly advises clients on issues relating to enforcement of foreign decrees and awards in India, service of foreign summons in India and bilateral investment treaties entered into with India. Saman has previously advised clients on complex disputes arising out of shareholder agreements, construction contracts, production sharing agreements etc.
Saman also regularly represents clients before the Supreme Court of India and various High Courts of the country in connection with their disputes in the field of pharma and healthcare, natural resources, environment, education and other regulatory laws.
Dispute Resolution
Advised on its enforcement proceedings for enforcement of a 1.1 billion USD arbitral award against an Indian telecom company in connection with breach of clauses relating to buy back of shares.
Represented and advised in their dispute with Indian parties in connection with procuring an exit from the Indian companies at the agreed exit price.
Advised on various litigation aspects in connection with its investment into an Indian Group of Hospitals.
Advised on litigation aspects in connection with its acquisition of overseas hotels of an Indian conglomerate.
Advised on dispute with a British–Swiss multinational commodity trading and mining company for breach of coal supply agreements.
Advised on arbitration dispute against the Government of India regarding disinvestment of a government undertaking.
Advised on disputes challenging the validity of Rule 8(4) of the Mineral (Other than Atomic and Hydro Carbons Energy Minerals) Concession Rules 2016 before various High Courts and the Hon’ble Supreme Court.
Advised on their disputes against Union of India regarding ban of Fixed Dose Combination Drugs before the Delhi High Court and the Supreme Court.
Advised on (i) its dispute with a Chinese manufacturer of API for defective quality (ii) various class action suits filed against it in the United States.
